Australia
FDA clearance of Salix® Coronary Plaque module
Significantly expands U.S. commercial opportunity with ability to charge fees per scan assessed Investor Webinar - 11.30am AEST (9.30am AWST) on 22 August 2025 PERTH, Australia, Aug. 21, 2025 /PRNewswire/ -- Artrya Limited (ASX: AYA) ( Artrya or the Company), a medical technology company commerc...
2025-08-21 19:43
1637
Karpowership and Seatrium Launch LNGTS Americas and Sign LoI for Next-Gen Floating Power Projects
ISTANBUL, Aug. 14, 2025 /PRNewswire/ -- Karpowership and Seatrium have celebrated the naming ofKaradeniz LNGTS Americas, the fifth member of Karpowership's LNG Terminal Ship (LNGTS) fleet. The ceremony also saw both companies sign a strategic partnership to convert the Karpowership's next-genera...
2025-08-14 18:36
2179
Alpha Global partners with LIO to redefine Mental Health Care in Australia
New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals SYDNEY, Aug. 14, 2025 /PRNewswire/ -- Alpha Global, a trusted provider of technology-driven solutions for healthcare and care providers inAustralia...
2025-08-14 11:00
2185
Australia's Prestigious Darwin Aboriginal Art Fair returns for its 19th Year, and you can access it online!
DARWIN, Australia, Aug. 7, 2025 /PRNewswire/ -- The world-renowned Darwin
Aboriginal Art Fair (DAAF) returns to Larrakia Country in Darwin,Australia, and
is online fromAugust 8 to 10 (2025), celebrating Australian Aboriginal and
Torres Strait Islander art, design and culture.
2025-08-08 08:35
1943
X‑Design Tops Product Hunt with One-Click Lifestyle Product Photos
— A new AI tool that helps small Home Décor brands create realistic listing
images without a studio
SYDNEY, Aug. 7, 2025 /PRNewswire/ -- X‑Design
2025-08-08 03:01
1726
Vmake AI Talking Video Editor: The All-in-One Solution for Talking Videos, Empowering Diverse Creators
SYDNEY, Aug. 7, 2025 /PRNewswire/ -- Vmake
2025-08-08 03:00
1925
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market
SYDNEY, Aug. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional investors for a private placement of equity securities (PIP...
2025-08-01 20:00
4728
A novel oral treatment for Alzheimer's: Actinogen's pivotal trial currently recruiting participants in the US
All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® vs. placebo for 36 weeks, followed by an open label extension of active Xanamem for up to 24 months SYDNEY, July 22, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is encouraging individu...
2025-07-22 20:00
1956
Co-PSMA trial: Recruitment successfully completed
SYDNEY, July 17, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...
2025-07-17 21:01
1995
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial
SYDNEY, July 9, 2025 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) is pleased to announce preliminary results from the first patient in its Phase1b trial evaluating a combination regimen of Paxalisib, pembrolizumab (Keytruda®), and standard chemotherapy after completing Cycle 1 (21 days) of d...
2025-07-09 20:00
3324
Mindsprint enhances ProcureSPRINT™ with Agentic AI to unlock up to 15% in procurement cost efficiencies
SINGAPORE, July 9, 2025 /PRNewswire/ -- Mindsprint
2025-07-09 14:37
2080
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...
2025-07-03 07:09
1921
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: * With the 100th participant enrolled in the XanaMIA trial, the timeline for the planned interim analysis is confirmed forJanuary 2026 and the timeline for final results reconfirmed for late 2026 * An...
2025-06-30 20:30
1624
QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- QBiotics CEO, Stephen Doyle, reflecting on Soft Tissue Sarcoma data * Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced S...
2025-06-25 18:05
1942
Academic friend or foe? Yugo research reveals how students supercharge their studies with AI
Despite academic advantages, substantial fears remain about AI's impact
LONDON, June 19, 2025 /PRNewswire/ -- As universities grapple with how to
effectively police AI, new Yugo research reveals the extent to which students
are using it as a powerful study companion.
2025-06-19 05:33
2255
Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program
PERTH, Australia, June 18, 2025 /PRNewswire/ -- Emyria Limited (ASX: EMD) ("Emyria", or the "Company") a leader in developing and delivering innovative mental health treatments, today announced a landmark partnership with Medibank, Australia's largest private health insurer. Under the multi-yea...
2025-06-18 20:00
2361
Polus holds €425 million initial close for third CLO equity fund
One of Europe's largest raises of its kind highlights Polus' leadership in the CLO and leveraged credit markets. LONDON, June 17, 2025 /PRNewswire/ -- Polus Capital Management ("Polus"), an investment management firm specialising in alternative credit strategies, is pleased to announce the initi...
2025-06-17 22:18
1961
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Highlights * Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for64Cu-SAR-bisPSMA. * SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and64Cu-SAR-bisPSMA under one roof and enables distribution to all 50 sta...
2025-06-17 21:04
1869
Ace Green Recycling and Enecell Announce Strategic Agreement to Advance Sustainable Battery Recycling in Australia
Ace to become Enecell's exclusive offtake partner for its lead battery
recycling facility inPerth
Commercial agreement is Ace's first in Australia, the world's largest lithium
producer
HOUSTON, June 16, 2025 /PRNewswire/ -- Ace Green Recycling
2025-06-16 20:00
1654
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
HIGHLIGHTS * A confirmed pathological complete response has been recorded in the ACCENT trial * A pathological complete response (pCR) is extremely rare in patients undergoing treatment for advanced pancreatic cancer * A pCR means that there are no signs of cancer in tissue examined by a p...
2025-06-16 19:00
1516
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 295 media titles]
2025-11-29 09:00
Pop the 90s: The Westin Surabaya and Four Points Pakuwon Indah Welcomes 2026 with a Spectacular Live Show Featuring Project Pop
[Picked up by 286 media titles]
2025-11-26 10:49
MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand
[Picked up by 284 media titles]
2025-12-01 08:30Lincah Acquires Orderfaz to Strengthen Southeast Asia's Social Commerce Infrastructure
[Picked up by 283 media titles]
2025-11-26 09:00
Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2702
